AFT Pharmaceuticals today announced an agreement with Hainan Haiyao Co Ltd to distribute Crystaderm cream in China.
Crystaderm cream is a proprietary product that treats skin infections by the slow release of hydrogen peroxide onto the skin as an alternative to topical antibiotics, which if misused risk development of drug resistant bacteria.
AFT's Managing Director Dr Hartley Atkinson said, "we anticipate the launch will occur during this calendar year, and believe that there is a significant potential for this product in such a large population base".
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Jul 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Jul 24